Avidity Biosciences, Inc.

NASDAQ:RNA

41.71 (USD) • At close September 13, 2024
Bedrijfsnaam Avidity Biosciences, Inc.
Symbool RNA
Munteenheid USD
Prijs 41.71
Beurswaarde 4,885,116,910
Dividendpercentage 0%
52-weken bereik 4.825 - 48.801
Industrie Biotechnology
Sector Healthcare
CEO Ms. Sarah Boyce
Website https://www.aviditybiosciences.com

An error occurred while fetching data.

Over Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle

Vergelijkbare Aandelen

Verve Therapeutics, Inc. logo

Verve Therapeutics, Inc.

VERV

5.5 USD

HealthStream, Inc. logo

HealthStream, Inc.

HSTM

28.78 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

5.8 USD

Merus N.V. logo

Merus N.V.

MRUS

50.14 USD

Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

AVIR

3.87 USD

Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

ATAI

1.3 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

5.99 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.31 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

2.78 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)